🕵️ Traws Pharma, Inc. ($TRAW)
SEC insider & ownership activity, last 12 months · CIK 1130598 · every row links its SEC filing
Over the last 12 months insiders bought $998K with no open-market selling against it. Orbimed Advisors LLC bought $998K (Apr). Orbimed Advisors LLC trimmed 19.9% → 11.9%; Orbimed Capital GP VIII LLC trimmed 19.9% → 11.9%. No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
1 buyer, $998K (4 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 4 | $998K | 0 | – | Apr 16, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Orbimed Advisors LLC | 11.9% | 13D | Apr 16, 2026 | filing ↗ | |
| Orbimed Capital GP VIII LLC | 11.9% | 13D | Apr 16, 2026 | filing ↗ | |
| Ikarian Capital, LLC | 10.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Neil Shahrestani | 10.0% | 13G | Feb 17, 2026 | filing ↗ | |
| Alyeska Investment Group, L.P. | 9.9% | 13G | Feb 14, 2025 | filing ↗ | |
| Alyeska Fund GP, LLC | 9.9% | 13G | Feb 14, 2025 | filing ↗ | |
| Anand Parekh | 9.9% | 13G | Feb 14, 2025 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd | 9.9% | 13G | Jan 8, 2025 | filing ↗ | |
| Adage Capital Management, L.P. | 9.1% | 13G | Feb 12, 2026 | filing ↗ | |
| Robert Atchinson | 9.1% | 13G | Feb 12, 2026 | filing ↗ | |
| Phillip Gross | 9.1% | 13G | Feb 12, 2026 | filing ↗ | |
| Chernett Jorey | 6.8% | 13G | Jan 16, 2026 | filing ↗ | |
| Squadron Master Fund LP | 6.4% | 13G | May 15, 2026 | filing ↗ | |
| Squadron Capital Management LLC | 6.4% | 13G | May 15, 2026 | filing ↗ | |
| Matthew Sesterhenn | 6.4% | 13G | May 15, 2026 | filing ↗ | |
| William Blank | 6.4% | 13G | May 15, 2026 | filing ↗ | |
| Perceptive Advisors LLC | 6.1% | 13G | May 15, 2026 | filing ↗ | |
| Joseph Edelman | 6.1% | 13G | May 15, 2026 | filing ↗ | |
| Perceptive Life Sciences Master Fund, Ltd. | 6.1% | 13G | May 15, 2026 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jul 10, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 8, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 8, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 8, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 12, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 12, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 27, 2026 | filing ↗ |
| Other events (8.01) | May 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 22, 2026 | filing ↗ |
| Earnings (2.02) | May 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | May 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 15, 2026 | filing ↗ |
| Earnings (2.02) | Apr 15, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Apr 15, 2026 | filing ↗ |
| Other events (8.01) | Apr 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 15, 2026 | filing ↗ |
| Other events (8.01) | Feb 19, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 19, 2026 | filing ↗ |
| Other events (8.01) | Jan 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 26, 2026 | filing ↗ |
| Other events (8.01) | Jan 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 13, 2026 | filing ↗ |
| Other events (8.01) | Dec 17, 2025 | filing ↗ |